Our Pricing

Buy Wegovy Online UK - All Doses In Stock & Ready

Published on: June 03, 2026

When you buy Wegovy online UK all doses from Cured Pharmacy, you're accessing the full range of semaglutide weight loss injections with transparent upfront pricing from £79.00 and a free clinical assessment by UK-registered prescribers. Our pharmacy holds all Wegovy doses in stock, ensuring you can begin or continue your weight management programme without delays.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the action of glucagon-like peptide-1, a natural hormone that regulates appetite and food intake by acting on areas of the brain involved in hunger control.

In the STEP 1 clinical trial, participants using Wegovy alongside lifestyle interventions achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results demonstrated that semaglutide can help patients achieve clinically significant weight loss when combined with a reduced-calorie diet and increased physical activity.

The medication works by slowing gastric emptying, which prolongs the sensation of fullness after meals, and by reducing appetite signals in the central nervous system [2]. This dual mechanism helps patients naturally reduce their caloric intake without experiencing the intense hunger that often undermines traditional weight loss efforts.

All Wegovy Doses Available at Cured Pharmacy

Wegovy follows a structured dose escalation schedule designed to optimise tolerability whilst building up to the therapeutic maintenance dose. At Cured Pharmacy, we stock all five Wegovy pen doses: 0.25mg, 0.5mg, 1mg, 1.7mg, and the full 2.4mg maintenance dose.

The standard titration schedule begins with 0.25mg once weekly for four weeks, then increases to 0.5mg for four weeks, followed by 1mg, 1.7mg, and finally the 2.4mg maintenance dose [3]. This gradual escalation significantly reduces the incidence and severity of gastrointestinal side effects, which are the most commonly reported adverse reactions during semaglutide treatment.

Having all doses in stock means you won't face treatment interruptions when progressing through your dose escalation schedule. Continuity of treatment is essential for achieving optimal weight loss outcomes, and supply gaps can disrupt both your physical progress and your psychological commitment to the programme.

Personalised Dosing by UK Prescribers

Your UK-registered prescriber will determine your appropriate starting dose and escalation schedule based on your medical history, current medications, and individual tolerability. Some patients may require a slower titration if they experience persistent gastrointestinal symptoms, whilst others progress smoothly through the standard schedule. Our clinical team monitors your response throughout treatment and can adjust your dosing plan accordingly.

Wegovy Price UK: Transparent Upfront Pricing from £89.00

At Cured Pharmacy, Wegovy is available from £79.00, with pricing displayed before you begin your online consultation. This transparent approach means you'll know the exact cost of your treatment before speaking with a prescriber, unlike services that only reveal pricing after lengthy consultations.

Our lowest price guarantee ensures you're receiving competitive UK pricing without compromising on service quality or medication authenticity. Every Wegovy pen dispensed from our pharmacy is UK-licensed, sourced through legitimate pharmaceutical supply chains, and verified by our superintendent pharmacist Tarun Kumar (GPhC 2233073).

The price includes your medication, clinical assessment by a UK prescriber, and discreet home delivery. There are no hidden consultation fees or surprise charges at checkout—what you see during product selection is what you pay.

Clinical Evidence: STEP Trial Programme Results

The approval of Wegovy for weight management was supported by the comprehensive STEP clinical trial programme, which enrolled over 4,500 participants across multiple studies [1][4]. These randomised, double-blind, placebo-controlled trials demonstrated both the efficacy and safety profile of semaglutide 2.4mg for chronic weight management.

In STEP 2, which specifically enrolled participants with type 2 diabetes, semaglutide 2.4mg produced an average weight reduction of 9.6% compared to 3.4% with placebo over 68 weeks [4]. This trial was particularly significant because it demonstrated that Wegovy's weight loss benefits extend to patients with metabolic comorbidities, not just those with obesity alone.

Beyond weight reduction, the STEP trials documented improvements in cardiometabolic risk factors including waist circumference, blood pressure, lipid profiles, and glycaemic control in participants with prediabetes or type 2 diabetes [1][4]. These secondary outcomes suggest that the benefits of semaglutide-induced weight loss extend beyond the number on the scale to meaningful health improvements.

Real-World Effectiveness

Clinical trial results represent controlled conditions with carefully selected participants and high adherence rates. Real-world observational studies have since confirmed that patients using Wegovy in routine clinical practice can achieve substantial weight loss, though average reductions may be somewhat lower than trial results due to variations in adherence, lifestyle modifications, and baseline characteristics [5]. Your individual response will depend on multiple factors including your starting weight, dietary habits, physical activity levels, and consistent medication use.

How to Buy Wegovy Online UK Through Cured Pharmacy

Purchasing Wegovy through Cured Pharmacy begins with a free online consultation that takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight management goals, and any contraindications that might affect your suitability for semaglutide treatment.

A UK-registered prescriber reviews your consultation responses, typically within hours during business days. If Wegovy is clinically appropriate for you, the prescriber will issue a prescription and your order will be dispensed by our GPhC-registered pharmacy (9012511). If semaglutide isn't suitable based on your medical profile, the prescriber will explain why and may suggest alternative treatments.

Your medication is dispatched in 100% discreet packaging with no external markings indicating the contents. Delivery timescales depend on your location and selected shipping method, with most UK addresses receiving orders within 2-3 working days of prescription approval.

Managing Side Effects and Treatment Expectations

The most frequently reported side effects of Wegovy are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal pain [3]. These symptoms are typically mild to moderate in severity and tend to diminish as your body adapts to the medication, particularly when following the recommended dose escalation schedule.

To minimise gastrointestinal discomfort, eat smaller meals throughout the day rather than large portions, avoid high-fat foods which slow digestion further, and stay well-hydrated. If nausea becomes troublesome, try taking your injection in the evening rather than morning, and avoid lying down immediately after eating.

Wegovy is intended for long-term use as part of a comprehensive weight management programme that includes dietary modifications and increased physical activity [3]. Weight loss typically begins within the first few weeks of treatment and continues as you escalate to higher doses. Most patients reach their maximum weight loss between 60-68 weeks of continuous treatment, after which the focus shifts to weight maintenance. Discontinuing Wegovy often results in weight regain, which is why ongoing treatment and lifestyle modifications are essential for sustained results [6].

When to Contact Your Prescriber

Contact your prescriber if you experience severe or persistent vomiting or diarrhoea that could lead to dehydration, signs of pancreatitis such as severe abdominal pain radiating to your back, or symptoms of gallbladder problems including right upper abdominal pain and yellowing of skin or eyes. Additionally, report any unusual lumps in your neck, persistent hoarseness, or difficulty swallowing, as these could indicate thyroid changes requiring evaluation. Your clinical team at Cured Pharmacy is available by phone on (+44) 116 4646009 for treatment-related queries.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., ... & Tschöp, M. H. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
5. Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., ... & Acosta, A. (2022). Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity. JAMA Network Open, 5(9), e2231982. https://doi.org/10.1001/jamanetworkopen.2022.31982 [accessed 13 August 2026]
6. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.